Reasons Oji Pet Clinic Decided on M&A: Solving Successor Issues and Passing Minimally Invasive Medicine to the Next Generation – STRIKE Co., Ltd.

According to news reported by STRIKE Co., Ltd., Oji Pet Clinic decided on an M&A to solve its successor problem and to pass on its specialized minimally invasive medicine to the next generation. This case suggests the challenges of business succession faced by medical corporations and clinics, and the effectiveness of M&A, highlighting schemes unique to medical corporations such as transfer of equity interests and change of members, corporate valuation that includes not only medical profits but also specialization and patient base, and the importance of stabilization support after succession.

What the Oji Pet Clinic Case Shows: The Intersection of Successor Issues and the Inheritance of Specialization in Medical Corporations

The M&A case of Oji Pet Clinic reported by STRIKE Co., Ltd. contains implications deeply related to the business succession problems faced by many medical corporations and clinics. The reasons cited for the clinic’s decision to pursue M&A are “solving the successor problem” and “passing on minimally invasive medicine to the next generation.” This clearly indicates an M&A motivation unique to medical institutions: not merely a change of management, but connecting specific specialized skills and medical know-how to the future.

Even in medical corporations, cases where intra-family succession becomes difficult are increasing due to the mandatory doctor’s license and the difficulty in securing doctors with specific specialized fields. In such circumstances, M&A from external parties becomes an effective option for maintaining and developing medical functions and continuing contributions to regional healthcare. The Oji Pet Clinic case can be said to re-present M&A as a realistic means to solve the dual challenges of successor issues and the inheritance of specialized skills for medical institutions providing highly specialized medical services.

The Importance of Intangible Asset Valuation in Medical Institution M&A, as Seen in the Inheritance of “Minimally Invasive Medicine”

The fact that Oji Pet Clinic cited the inheritance of “minimally invasive medicine” as a primary reason for M&A highlights the extreme importance of intangible assets in the corporate valuation of medical institutions. The value of a medical institution is not measured solely by tangible fixed assets like real estate and medical equipment, or by financial indicators such as medical revenue.

Especially in the case of highly specialized clinics, “intangible assets” such as the director’s outstanding skills, clinical know-how cultivated over many years, treatment achievements for specific diseases, strong trust relationships with patients, and skilled staff supporting that specialization often constitute a significant portion of the corporate value. These intangible assets are key to ensuring the continuity and quality of medical care and maintaining the patient base even after the transfer. When considering M&A, how these intangible assets are appropriately valued and how the acquiring party can maximize their value are crucial factors for success.

Schemes Unique to Medical Corporation M&A and Perspectives on Stabilization After Succession

In M&A of medical corporations, specific schemes are used depending on the corporate form. “Transfer of equity interests,” “change of members,” and “repayment of endowment funds,” as mentioned in the news highlights, are typical examples. In the case of a medical corporation (Iryo Hojin Shadan) with equity interests, the transfer of equity interests is the primary means of transferring management rights, but issues such as capital gains taxation and the proper valuation of equity interests become important. On the other hand, in the case of endowment-based medical corporations or non-equity medical corporations (Iryo Hojin Shadan without equity), management rights are transferred through procedures for the repayment of endowment funds and the change of members/directors.

M&A is not over once the deal is closed. Especially in medical institutions, a smooth transition to the new system and stable operation are extremely important. Addressing a wide range of issues is required, such as maintaining the employment and motivation of existing staff, providing careful information to patients and ensuring continuity of medical care, and considering regional medical collaboration. For both the transferring and acquiring parties, post-M&A support and alignment of management philosophy and medical policies can be said to hold the key to success.

If you are specifically considering the succession or M&A of a medical corporation or clinic, please use our free quick assessment or individual consultation (strict confidentiality and a complete success fee system).